Morgan Stanley Meets with CVS Health (CVS) To Discuss Company Structure in a Post Covid World - 5 Takeaways
Tweet Send to a Friend
Morgan Stanley analyst Ricky Goldwasser reiterated an Overweight rating and $92.00 price target on CVS Health (NYSE: CVS) after meeting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
